US Broker Ratings

Autolus Therapeutics (AUTL): An Investor Outlook with Nearly 500% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company based in London, is making waves in the biotechnology sector with its pioneering T cell therapies for..

Inventiva S.A. (IVA) Stock Analysis: Eyeing a 241.50% Potential Upside with Strong Buy Ratings

Inventiva S.A. (NASDAQ: IVA), a French biotech company, has recently attracted significant attention from investors due to its promising clinical-stage pipeline and substantial potential upside of..

Amylyx Pharmaceuticals, Inc. (AMLX) Investor Outlook: Exploring a 55% Potential Upside Amidst Biotech Innovations

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands out in the biotechnology sector with its promising pipeline of treatments targeting neurodegenerative diseases and rare endocrine conditions. Headquartered in..

Tilray Brands, Inc. (TLRY) Investor Outlook: Exploring a 91.78% Potential Upside

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent player in the global cannabis and consumer lifestyle product sectors, presents a unique case for investors seeking exposure to..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Biotechnology Innovator Offers a Promising 55.25% Upside Potential

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a trailblazer in the biotechnology sector, has been gaining traction among investors due to its pioneering approach in developing monoclonal antibody..

Sionna Therapeutics (SION) Stock Analysis: Navigating the Biotech Wave with a 2% Upside Potential

Sionna Therapeutics, Inc. (NASDAQ: SION) has captured investor attention within the biotechnology sector, particularly for its pioneering work in developing therapies for cystic fibrosis (CF). As..

MBX Biosciences, Inc. (MBX) Stock Analysis: Assessing a 106% Potential Upside in Biotech

Investors eyeing opportunities in the biotechnology sector may find MBX Biosciences, Inc. (MBX) a compelling prospect, given its impressive potential upside and active pipeline. This clinical-stage..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a 69.67% Upside Potential in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company, has been capturing investor attention with its promising pipeline aimed at treating various forms of cancer. Headquartered in..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 71% Potential Upside in Cutting-Edge Cell Therapies

Investors looking for opportunities in the burgeoning field of biotechnology may find Sana Biotechnology, Inc. (NASDAQ: SANA) a compelling proposition. With a market capitalization of $1.33..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Unveiling a 435% Upside Potential in Biotech

For investors with an eye on the healthcare sector, Anavex Life Sciences Corp. (NASDAQ: AVXL) presents a compelling opportunity. This biopharmaceutical company, with a focus on..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: A Look at Its 78.20% Potential Upside

For investors navigating the intricate landscape of the healthcare sector, Organogenesis Holdings Inc. (NASDAQ: ORGO) presents an intriguing opportunity. With a market capitalization of $605.37 million,..

Sonida Senior Living, Inc. (SNDA): Investor Outlook Amidst 25.9% Revenue Growth and Technical Challenges

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector specializing in medical care facilities, is navigating a complex financial landscape. Despite a commendable..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring the 499.78% Potential Upside

For investors seeking opportunities in the biotechnology sector, Humacyte, Inc. (NASDAQ: HUMA) presents an intriguing proposition. This Durham, North Carolina-based company is making waves in the..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Promising Biotech with 78% Upside Potential

Relay Therapeutics, Inc. (RLAY) is gaining attention in the biotech sector with a compelling proposition for investors keen on innovative healthcare opportunities. Headquartered in Cambridge, Massachusetts,..

Neuropace, Inc. (NPCE) Stock Analysis: Navigating a 29.90% Revenue Growth in the Medical Devices Arena

Investors with a keen eye on the healthcare sector might find NeuroPace, Inc. (NASDAQ: NPCE) an intriguing opportunity. Specializing in innovative medical devices, NeuroPace has captured..

Auna SA (AUNA) Investor Outlook: Exploring a Potential 121% Upside

Auna SA (AUNA), a Luxembourg-based healthcare service provider, is currently capturing the attention of investors with its significant potential upside. With a market cap of $348.6..

iRadimed Corporation (IRMD) Stock Analysis: Exploring Growth in the Medical Device Sector

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector specializing in medical devices, has attracted considerable attention from investors due to its impressive growth..

HealthStream, Inc. (HSTM) Stock Analysis: Unlocking a 39.69% Potential Upside in Healthcare SaaS

Investors eyeing the healthcare sector may find HealthStream, Inc. (HSTM) an intriguing opportunity, particularly with its significant potential upside of 39.69%. As a key player in..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Innovator with 118% Upside Potential

Claritev Corporation (CTEV), a prominent player in the health information services industry, has caught the attention of investors with its compelling growth potential and innovative solutions..

Beta Bionics, Inc. (BBNX) Stock Analysis: High Revenue Growth and Analyst Confidence in Healthcare Innovator

Beta Bionics, Inc. (NASDAQ: BBNX), a frontier player in the medical devices sector, is capturing investor attention with its innovative approach to diabetes management and a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds